Parkinson's patch gets FDA approval; NC plays host to nanotech summit;

> Neupro, a dopamine agonist patch for Parkinson's and restless-leg syndrome, got FDA approval, and its producer, Belgium's UCB, plans for a July launch in the U.S. Release

> North Carolina is playing host to the Nanotech Commercialization Conference this week, and with 40 nanobiotechnology companies in the state alone, the field could be a huge boon to the local economy. Story

> Frost Gamma Investments Trust bought about 24 million shares of Alliqua ($ALQA), a New York-based company developing a transdermal drug delivery platform using a proprietary hydrogel. Release

> Nordson ASYMTEK has joined forces with the University of Greenwich to develop state-of-the-art drug delivery systems using the company's DispenseMate D-583 benchtop dispensing technology. Report

And Finally... Inovio Pharmaceuticals ($INO) scored a $750,000 grant from the Department of Defense to test the safety of its surface electroporation drug delivery system, with the aim of developing synthetic vaccines to combat bioterrorism. News

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.